Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Barcellini, W
176  Ergebnisse:
Personensuche X
?
1

P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND RE..:

van Beers, E. J. ; Al-Samkari, H. ; Grace, R. F....
HemaSphere.  6 (2022)  - p. 1446-1447 , 2022
Link: https://doi.org/10.1097/..
 
?
2

S304: SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, PROVIDES SUST..:

Röth, A. ; Broome, C. M. ; Barcellini, W....
HemaSphere.  6 (2022)  - p. 205-206 , 2022
Link: https://doi.org/10.1097/..
 
?
3

PB2345: ADAPTING PATIENT EDUCATIONAL APPROACHES IN PYRUVATE..:

Barcellini, W. ; Grace, R.
HemaSphere.  6 (2022)  - p. 2214-2215 , 2022
Link: https://doi.org/10.1097/..
 
?
4

P1526: AUTOIMMUNE HEMOLYTIC ANEMIAS: RELATIONSHIP BETWEEN S..:

Zaninoni, A. ; Fattizzo, B. ; Giannotta, J....
HemaSphere.  6 (2022)  - p. 1407-1408 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN T..:

Grace, R. F. ; Glenthøj, A. ; Barcellini, W....
HemaSphere.  6 (2022)  - p. 1426-1427 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P1725: OBSERVATIONAL STUDY TO EVALUATE PATIENT-REPORTED OUT..:

Urciuoli, E. ; Di Bona, E. ; Greve, S....
HemaSphere.  6 (2022)  - p. 1606-1607 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P1548: LONG-TERM TREATMENT WITH ORAL MITAPIVAT IS ASSOCIATE..:

Barcellini, W. ; Grace, R. F. ; Al-Samkari, H....
HemaSphere.  6 (2022)  - p. 1429-1430 , 2022
Link: https://doi.org/10.1097/..
 
?
8

P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACE..:

Barcellini, W. ; Butler, K. ; Moran, S....
HemaSphere.  6 (2022)  - p. 1414-1415 , 2022
Link: https://doi.org/10.1097/..
 
?
9

Autoimmune hemolytic anemia: causes and consequences:

Fattizzo, B ; Barcellini, W
Expert Review of Clinical Immunology.  18 (2022)  7 - p. 731-745 , 2022
Link: https://doi.org/10.1080/..
 
?
10

P1525: MANAGEMENT OF AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING P..:

Bortolotti, M. ; Fantini, N. N. ; Glenthoj, A....
HemaSphere.  6 (2022)  - p. 1406-1407 , 2022
Link: https://doi.org/10.1097/..
 
?
11

P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATI..:

Röth, A. ; Barcellini, W. ; D'Sa, S....
HemaSphere.  6 (2022)  - p. 1419-1420 , 2022
Link: https://doi.org/10.1097/..
 
?
12

P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIV..:

Kuo, K. H. ; Grace, R. F. ; van Beers, E. J....
HemaSphere.  6 (2022)  - p. 1616-1617 , 2022
Link: https://doi.org/10.1097/..
 
?
13

S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIE..:

Röth, A. ; Barcellini, W. ; D'Sa, S....
HemaSphere.  6 (2022)  - p. 186-187 , 2022
Link: https://doi.org/10.1097/..
 
?
14

P1555: IRON CHELATION THERAPY IN CONGENITAL HEMOLYTIC ANEMI..:

Bosi, A. ; Fattizzo, B. ; Giannotta, J. A...
HemaSphere.  6 (2022)  - p. 1436-1437 , 2022
Link: https://doi.org/10.1097/..
 
?
15

PB1935: MANAGEMENT OF NON-SEVERE APLASTIC ANEMIA: LABORATOR..:

Cassanello, G. ; Giannotta, J. A. ; Cro, L....
HemaSphere.  6 (2022)  - p. 1811-1812 , 2022
Link: https://doi.org/10.1097/..
 
1-15